BIOVENTUS INC - A (BVS) Stock Fundamental Analysis
USA - NASDAQ:BVS - US09075A1088 - Common Stock
7.2 USD
+0.27 (+3.9%)
7.2 USD
0 (0%)
Overall BVS gets a fundamental rating of 4 out of 10. We evaluated BVS against 191 industry peers in the Health Care Equipment & Supplies industry. There are concerns on the financial health of BVS while its profitability can be described as average. A decent growth rate in combination with a cheap valuation! Better keep an eye on BVS.
1. Profitability
1.1 Basic Checks
In the past year BVS was profitable.
In the past year BVS had a positive cash flow from operations.
In multiple years BVS reported negative net income over the last 5 years.
Of the past 5 years BVS 4 years had a positive operating cash flow.
1.2 Ratios
BVS has a better Return On Assets (-0.02%) than 71.20% of its industry peers.
BVS's Return On Equity of -0.10% is fine compared to the rest of the industry. BVS outperforms 71.73% of its industry peers.
BVS has a Return On Invested Capital of 6.08%. This is amongst the best in the industry. BVS outperforms 81.15% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.02% | ||
| ROE | -0.1% | ||
| ROIC | 6.08% |
ROA(3y)-11.81%
ROA(5y)-6.59%
ROE(3y)-54.27%
ROE(5y)-31.1%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
BVS's Operating Margin of 7.11% is fine compared to the rest of the industry. BVS outperforms 74.35% of its industry peers.
BVS's Operating Margin has declined in the last couple of years.
BVS has a Gross Margin of 67.60%. This is in the better half of the industry: BVS outperforms 74.35% of its industry peers.
BVS's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 7.11% | ||
| PM (TTM) | N/A | ||
| GM | 67.6% |
OM growth 3Y-2.88%
OM growth 5Y-14.52%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.21%
GM growth 5Y-1.56%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), BVS is destroying value.
The number of shares outstanding for BVS has been increased compared to 1 year ago.
Compared to 5 years ago, BVS has more shares outstanding
The debt/assets ratio for BVS has been reduced compared to a year ago.
2.2 Solvency
Based on the Altman-Z score of 1.07, we must say that BVS is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 1.07, BVS is in line with its industry, outperforming 53.40% of the companies in the same industry.
The Debt to FCF ratio of BVS is 10.30, which is on the high side as it means it would take BVS, 10.30 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of BVS (10.30) is better than 73.30% of its industry peers.
BVS has a Debt/Equity ratio of 1.90. This is a high value indicating a heavy dependency on external financing.
BVS has a worse Debt to Equity ratio (1.90) than 83.25% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.9 | ||
| Debt/FCF | 10.3 | ||
| Altman-Z | 1.07 |
ROIC/WACC0.72
WACC8.46%
2.3 Liquidity
BVS has a Current Ratio of 1.48. This is a normal value and indicates that BVS is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.48, BVS is doing worse than 75.39% of the companies in the same industry.
BVS has a Quick Ratio of 1.48. This is a bad value and indicates that BVS is not financially healthy enough and could expect problems in meeting its short term obligations.
BVS's Quick ratio of 0.96 is on the low side compared to the rest of the industry. BVS is outperformed by 78.01% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.48 | ||
| Quick Ratio | 0.96 |
3. Growth
3.1 Past
BVS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 31.58%, which is quite impressive.
The earnings per share for BVS have been decreasing by -16.93% on average. This is quite bad
Looking at the last year, BVS shows a small growth in Revenue. The Revenue has grown by 5.07% in the last year.
BVS shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 11.01% yearly.
EPS 1Y (TTM)31.58%
EPS 3Y-16.93%
EPS 5YN/A
EPS Q2Q%10.53%
Revenue 1Y (TTM)5.07%
Revenue growth 3Y9.98%
Revenue growth 5Y11.01%
Sales Q2Q%-2.35%
3.2 Future
Based on estimates for the next years, BVS will show a very strong growth in Earnings Per Share. The EPS will grow by 23.03% on average per year.
Based on estimates for the next years, BVS will show a small growth in Revenue. The Revenue will grow by 4.19% on average per year.
EPS Next Y38.25%
EPS Next 2Y32.75%
EPS Next 3Y23.03%
EPS Next 5YN/A
Revenue Next Year0.2%
Revenue Next 2Y3.49%
Revenue Next 3Y4.19%
Revenue Next 5YN/A
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
BVS is valuated correctly with a Price/Earnings ratio of 14.40.
BVS's Price/Earnings ratio is rather cheap when compared to the industry. BVS is cheaper than 87.43% of the companies in the same industry.
BVS is valuated rather cheaply when we compare the Price/Earnings ratio to 27.41, which is the current average of the S&P500 Index.
The Price/Forward Earnings ratio is 8.69, which indicates a very decent valuation of BVS.
Based on the Price/Forward Earnings ratio, BVS is valued cheaply inside the industry as 96.34% of the companies are valued more expensively.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.88, BVS is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 14.4 | ||
| Fwd PE | 8.69 |
4.2 Price Multiples
BVS's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. BVS is cheaper than 90.05% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, BVS is valued cheaply inside the industry as 89.01% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 17.46 | ||
| EV/EBITDA | 10.05 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as BVS's earnings are expected to grow with 23.03% in the coming years.
PEG (NY)0.38
PEG (5Y)N/A
EPS Next 2Y32.75%
EPS Next 3Y23.03%
5. Dividend
5.1 Amount
No dividends for BVS!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
7.2
+0.27 (+3.9%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners72.05%
Inst Owner Change2.29%
Ins Owners2.56%
Ins Owner Change3.49%
Market Cap595.30M
Analysts77.5
Price Target14.96 (107.78%)
Short Float %3.12%
Short Ratio4.13
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)119.26%
Min EPS beat(2)-0.99%
Max EPS beat(2)239.51%
EPS beat(4)3
Avg EPS beat(4)103.69%
Min EPS beat(4)-0.99%
Max EPS beat(4)239.51%
EPS beat(8)7
Avg EPS beat(8)172.93%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)0.02%
Min Revenue beat(2)-0.04%
Max Revenue beat(2)0.07%
Revenue beat(4)3
Avg Revenue beat(4)2.02%
Min Revenue beat(4)-0.04%
Max Revenue beat(4)4.79%
Revenue beat(8)7
Avg Revenue beat(8)4.23%
Revenue beat(12)9
Avg Revenue beat(12)1.98%
Revenue beat(16)11
Avg Revenue beat(16)1.72%
PT rev (1m)4.76%
PT rev (3m)-2.22%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-28.57%
EPS NY rev (1m)-8.96%
EPS NY rev (3m)-2.03%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.61%
Revenue NY rev (1m)0.13%
Revenue NY rev (3m)0.15%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 14.4 | ||
| Fwd PE | 8.69 | ||
| P/S | 1.06 | ||
| P/FCF | 17.46 | ||
| P/OCF | 16.42 | ||
| P/B | 3.69 | ||
| P/tB | N/A | ||
| EV/EBITDA | 10.05 |
EPS(TTM)0.5
EY6.94%
EPS(NY)0.83
Fwd EY11.5%
FCF(TTM)0.41
FCFY5.73%
OCF(TTM)0.44
OCFY6.09%
SpS6.82
BVpS1.95
TBVpS-2.82
PEG (NY)0.38
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.02% | ||
| ROE | -0.1% | ||
| ROCE | 7.7% | ||
| ROIC | 6.08% | ||
| ROICexc | 6.49% | ||
| ROICexgc | 33.79% | ||
| OM | 7.11% | ||
| PM (TTM) | N/A | ||
| GM | 67.6% | ||
| FCFM | 6.04% |
ROA(3y)-11.81%
ROA(5y)-6.59%
ROE(3y)-54.27%
ROE(5y)-31.1%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y44.62%
ROICexcg growth 5Y-8.7%
ROICexc growth 3Y36.86%
ROICexc growth 5Y-12.41%
OM growth 3Y-2.88%
OM growth 5Y-14.52%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.21%
GM growth 5Y-1.56%
F-Score7
Asset Turnover0.8
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.9 | ||
| Debt/FCF | 10.3 | ||
| Debt/EBITDA | 3.46 | ||
| Cap/Depr | 4.42% | ||
| Cap/Sales | 0.38% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 40.86% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.48 | ||
| Quick Ratio | 0.96 | ||
| Altman-Z | 1.07 |
F-Score7
WACC8.46%
ROIC/WACC0.72
Cap/Depr(3y)9.96%
Cap/Depr(5y)13.06%
Cap/Sales(3y)1.19%
Cap/Sales(5y)1.31%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)31.58%
EPS 3Y-16.93%
EPS 5YN/A
EPS Q2Q%10.53%
EPS Next Y38.25%
EPS Next 2Y32.75%
EPS Next 3Y23.03%
EPS Next 5YN/A
Revenue 1Y (TTM)5.07%
Revenue growth 3Y9.98%
Revenue growth 5Y11.01%
Sales Q2Q%-2.35%
Revenue Next Year0.2%
Revenue Next 2Y3.49%
Revenue Next 3Y4.19%
Revenue Next 5YN/A
EBIT growth 1Y188.15%
EBIT growth 3Y6.82%
EBIT growth 5Y-5.11%
EBIT Next Year17.28%
EBIT Next 3Y13.26%
EBIT Next 5YN/A
FCF growth 1Y336.04%
FCF growth 3Y34.24%
FCF growth 5Y-0.3%
OCF growth 1Y103.28%
OCF growth 3Y19.05%
OCF growth 5Y-0.96%